Clinical Trial Update: Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether acetylsalicylic acid reduces flushing caused by Niaspan in adults with dyslipidemia; the study is completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Aspirin (Aspirin)
• Niaspan (niacin (nicotinic acid))

Snippet

Sponsor: Abbott | Conditions: Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2009-08-25